.webp)
The All-on-4 concept was developed by Paulo Maló and formalised in collaboration with Nobel Biocare in the early 2000s. It addressed a specific clinical problem: patients with full-arch tooth loss and partial bone resorption who required a fixed prosthesis but whose bone anatomy made conventional complete implant placement across the arch impossible without extensive augmentation. The insight was to use four strategically placed implants — two axial anteriorly, two tilted posteriorly — to support a full-arch fixed bridge without bone grafting. See our All-on-4 treatment page and our same-day implant page for how this protocol is applied at Dazzle today.
The Biomechanical Logic
The angled posterior implants serve one mechanical function: they maximise the anterior-posterior (AP) spread — the distance between the most forward and most rearward implant. Greater AP spread means greater load distribution across the arch, smaller cantilever requirement, and lower bending moment at the posterior implant connections. The 30–45-degree angulation of the posterior implants allows them to emerge at the molar region despite entering the bone anteriorly to the sinus floor in the upper jaw and anterior to the mental foramen in the lower jaw.
This mechanical logic is explained in detail in our article on All-on-4 strategic implant placement. The prosthesis design — zirconia, PMMA, or hybrid ceramic — determines the final aesthetic and functional properties of the bridge.
What Maló's Original Protocol Specified
The Nobel Active implant system was the original implant of choice — chosen specifically for its aggressive thread design, which achieves high primary stability in soft posterior maxillary bone where conventional thread designs fail to reach threshold insertion torque for immediate loading. The multi-unit abutments (MUAs) are placed at time of surgery; these redirect the angled implant axis to allow a screw-retained bridge with near-axial screw access. The provisional bridge is fabricated before surgery and attached on the day of placement — the patient's teeth are extracted, implants placed, abutments attached, and the provisional bridge screwed in during a single surgical appointment.
How the Protocol Has Evolved
The original protocol has been adapted over two decades. Alternative implant systems (MegaGen AnyRidge, Straumann BLX) have demonstrated equivalent or superior primary stability in posterior bone. The prosthesis materials have evolved: PMMA provisional bridges have been increasingly replaced with final monolithic zirconia bridges delivered at 3–6 months. The protocol has been extended to six implants (All-on-6) and to hybrid approaches incorporating zygomatic or pterygoid implants where bone is severely atrophic. See our zirconia vs e.max crown guide for prosthesis material comparison.
The Nobel Biocare Ecosystem
Nobel Biocare's ecosystem for All-on-4 includes the Nobel Active implant, the Nobel Clinician surgical planning software, and the pre-fabricated multi-unit abutments standardised to the system. This ecosystem is one reason the All-on-4 protocol scaled globally — the components and planning tools were standardised, making training and replication across clinics more consistent. At Dazzle, Nobel Biocare systems are available alongside MegaGen and Straumann for All-on-4 cases, with system selection based on the specific bone anatomy of each case.
Prosthetic Options Under the All-on-4 Protocol
Provisional bridge: PMMA (acrylic) or interim composite, placed on the day of surgery. Worn during the 3–6 month osseointegration period. Final bridge: monolithic zirconia (most common at Dazzle for its durability and translucency), implant-supported fixed hybrid (zirconia framework + individual crowns), or PFM bridge (rarely used today). Each material option involves different occlusal design, wear characteristics, and maintenance requirements.
FAQs
Q1: Is the All-on-4 protocol the same at all clinics?
The mechanical principles are the same. The execution — implant system selection, primary stability assessment, guided surgery use, provisional fabrication, and prosthetic material — varies significantly between clinics. The published outcomes for All-on-4 reflect properly executed protocols; deviations from those protocols produce different outcomes.
Q2: Can All-on-4 be done with any implant brand?
In principle, yes. In practice, the posterior tilted implant position requires an implant system that achieves adequate insertion torque in softer posterior bone. Nobel Active, MegaGen AnyRidge, and Straumann BLX are the systems with the strongest published data for this application. Generic or unfamiliar brands may not achieve equivalent torque in the same bone conditions.
Q3: What is the long-term survival rate for All-on-4?
Published 10-year data from multiple independent centres show implant survival rates of 94–97% and prosthesis survival rates of 92–95% for properly executed All-on-4 cases. These figures apply to cases meeting the original protocol requirements — adequate primary stability, correct AP spread, appropriate provisional loading.
Q4: What happens if one implant fails after All-on-4?
The bridge depends on where the failure occurred and the load distribution. In most cases, the failed implant is removed and the prosthesis is supported on the remaining three implants temporarily while the replacement implant is placed and integrated.
